Both in Pharmaceuticals
SCYNEXIS vs Grace Therapeutics
Over the past year SCYX returned −23.8% and GRCE returned −41.4%; their daily moves had a correlation of 0.02.
SCYX −23.8% GRCE −41.4%Growth of $1, one year, split-adjusted
| Metric | SCYX | GRCE |
|---|---|---|
| Price | $3.84 | $1.81 |
| Market cap | $38.2M | $38.1M |
| Today | −2.54% | −1.63% |
| 1 month | −20.7% | −12.3% |
| 6 months | −51.1% | −23.6% |
| Year to date | −24.1% | −47.7% |
| 1 year | −24.8% | −41.8% |
| Revenue growth (YoY) | −82.8% | — |
| Gross margin | 100.0% | — |
| Net margin | 3147.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | $54.1M | $13.8M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 43.8% |
| Short % of float | 4.7% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).